• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Hindustan Unilever Ltd
Industry :  Personal Care - Multinational
BSE Code
ISIN Demat
Book Value()
500696
INE030A01027
208.3339342
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HINDUNILVR
51.14
547219.8
EPS(TTM)
Face Value()
Div & Yield %
45.54
1
2.28
 

Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
Feb 13,2026
Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.